Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorivudine for pediatric HIV patients with varicella-zoster virus
NCT00002358Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sorivudine in varicella zoster virus infection, sponsored by Bristol Myers Squibb. Status: completed.
02
Drugs
sorivudine
03
Conditions
varicella zoster virus infection
Beyond the preview
Go deeper on NCT00002358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002358.